SCHEMBL8346141

SCHEMBL8346141

COc1ccc2[nH]c(C=CC=O)cc2c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AXL P30530 1/20 0.54
PDGFRB P09619 3/20 0.53
PDGFRA P16234 2/20 0.53
CA2 P00918 1/20 0.50
LOXL2 Q9Y4K0 1/20 0.49
KDM4E B2RXH2 3/20 0.48
ALDH1A1 P00352 2/20 0.48
POLB P06746 1/20 0.48
GAA P10253 1/20 0.48
MEN1 O00255 2/20 0.48
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
KMT2A Q03164 2/20 0.48
MAPT P10636 1/20 0.48
FLT3 P36888 6/20 0.47
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2C9 P11712 1/20 0.46
TSHR P16473 1/20 0.46
HDAC6 Q9UBN7 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8346137 1.00 AXL (0.54) AXLPDGFRBPDGFRACA2LOXL2
SCHEMBL29953506 0.85 AXL (0.59) AXLPDGFRBPDGFRACA2LOXL2
SCHEMBL92643 0.85 AXL (0.59) AXLPDGFRBPDGFRACA2LOXL2
SCHEMBL11160132 0.80 AXL (0.61) AXLPDGFRBPDGFRACA2LOXL2
SCHEMBL5829214 0.79 PDGFRB (0.57) AXLPDGFRBPDGFRACA2KDM4E
SCHEMBL5829213 0.79 PDGFRB (0.57) AXLPDGFRBPDGFRACA2KDM4E
SCHEMBL5828737 0.79 AXL (0.59) AXLPDGFRBPDGFRACA2LOXL2
SCHEMBL8350229 0.78 ATP6V1B1 (0.59) AXLPDGFRBPDGFRAKDM4EALDH1A1
SCHEMBL8350238 0.78 ATP6V1B1 (0.59) AXLPDGFRBPDGFRAKDM4EALDH1A1
SCHEMBL8350233 0.78 ATP6V1B1 (0.59) AXLPDGFRBPDGFRAKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5981525-A FOR THERAPY OR PROPHYLAXIS OF OSTEOPOROSIS,TUMOURS, ULCERS, AUTOIMMUNE DISEASES, LIPIDEMIC DISORDERS, HYPERCHOLESTEROLEMIC AND ATHEROSCLEROTIC DISEASES, AIDS ALZHEIMER'S DISEASE SMITHKLINE BEECHAM CORPORATION (US) 1999-11-09 US disclosed
EP-0802902-A1 INDOLE DERIVATIVES USEFUL IN THE TREATMENT OF OSTEOPOROSIS Smithkline Beecham S.p.A. (IT) 1997-10-29 EP disclosed
WO-1996021644-A1 INDOLE DERIVATIVES USEFUL IN THE TREATMENT OF OSTEOPOROSIS SMITHKLINE BEECHAM S.P.A. (IT) 1996-07-18 WO disclosed